Hyaluronic acid increases tendon derived cell viability and collagen type I expression in vitro: Comparative study of four different Hyaluronic acid preparations by molecular weight

BACKGROUND: Hyaluronic Acid (HA) has been already approved by Food and Drug Administration (FDA) for osteoarthritis (OA), while its use in the treatment of tendinopathy is still debated. The aim of this study was to evaluate in human rotator cuff tendon derived cells the effects of four different HA...

Descripción completa

Detalles Bibliográficos
Autores principales: Osti, Leonardo, Berardocco, Martina, di Giacomo, Viviana, Di Bernardo, Graziella, Oliva, Francesco, Berardi, Anna C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2015
Materias:
Research Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596363/
https://www.ncbi.nlm.nih.gov/pubmed/26444018
http://dx.doi.org/10.1186/s12891-015-0735-7

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4596363/
https://www.ncbi.nlm.nih.gov/pubmed/26444018
http://dx.doi.org/10.1186/s12891-015-0735-7

Ejemplares similares